Regenerative medicine developing treatments to repair or re-grow
specific tissue in the body in the field of medical research.A person who own
cord blood stem cells can be safely infused back into that individual without
being rejected by the body’s immune system - and because they have the same or unique
characteristics compared to other sources of stem cells - they are an
increasing focus of regenerative medicine research.
Physicians and researchers are making significant progress
evaluating the safety and efficacy of umbilical cord blood stem cells for
therapeutic uses far beyond their uses for cancers and blood disorders.There is
no issue of panicking or thinking of side effects that can arise.
The use of cord blood stem cells in treating conditions such as
brain injury and Type 1 Diabetes is already being studied in humans, and earlier stage
research is being conducted for treatments of stroke, and hearing loss.
Current estimates indicate that approximately 1 in 3 Americans
could benefit from regenerative medicine, and
children whose cord blood stem cells are available for their own potential use
could be among the first to benefit from new therapies as they become
available. With autologous (the person’s own) cells, there is no risk of the
immune system rejecting the cells, so physicians and researchers are only
performing these potential cord blood therapies on children who have their own
stem cells available.
Research in this area that has
the potential to revolutionize medicine is advancing rapidly, and it is
difficult for professional medical societies, and other resources that
expectant parents turn to for information, to keep pace.
No comments:
Post a Comment